| 000 | 01399 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518050041.0 | ||
| 264 | 0 | _c20200921 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.14788 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Pengyun | |
| 245 | 0 | 0 |
_aMibefradil, a T-type Ca _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _c10 2019 |
||
| 300 |
_a3845-3856 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCalcium _xanalysis |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xchemistry |
| 650 | 0 | 4 |
_aCalcium Channels _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMibefradil _xchemistry |
| 650 | 0 | 4 |
_aORAI1 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aORAI2 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 | _aOptical Imaging |
| 700 | 1 | _aRubaiy, Hussein N | |
| 700 | 1 | _aChen, Gui-Lan | |
| 700 | 1 | _aHallett, Thomas | |
| 700 | 1 | _aZaibi, Nawel | |
| 700 | 1 | _aZeng, Bo | |
| 700 | 1 | _aSaurabh, Rahul | |
| 700 | 1 | _aXu, Shang-Zhong | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 176 _gno. 19 _gp. 3845-3856 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.14788 _zAvailable from publisher's website |
| 999 |
_c29867818 _d29867818 |
||